Insider · CIK 0001754129

Gover Justin D.

Reports to the SEC for 4 companies · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001754129

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	DSGNDesign Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2026-06-03	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Director	AAward	+1,593 sh	—	—	1,593
2026-06-03	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,507
2026-06-01	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,645 sh	—	—	0
2026-06-01	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,645 sh	—	—	2,645
2026-05-27	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+21.1K sh	—	—	21,110
2026-01-02	DSGNDesign Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-09-09	DSGNDesign Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+15.8K sh	—	—	15,833
2025-09-09	DSGNDesign Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-07-29	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+52K sh	—	—	52,000
2025-06-05	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,012
2025-06-05	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Director	AAward	+2,645 sh	—	—	2,645
2024-06-05	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,542
2023-08-10	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28K sh	—	—	28,000
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−119K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−223K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−148K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−142K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−263K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−213K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−164K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−480K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−75.9K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−288K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−55.5K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−17.5K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−12.5K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−227K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−1.87M sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−34K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−456K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−22.4K sh	—	—	0
2021-05-05	GW PHARMACEUTICALS PLCShare OptionsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−30.9K sh	—	—	0
2021-03-19	GW PHARMACEUTICALS PLCG Gift	Director, Chief Executive Officer	GGift	−276K sh	—	—	1,867,308
2021-03-02	GW PHARMACEUTICALS PLCShare OptionsA Award	Director, Chief Executive Officer	AAward	+164K sh	—	—	164,496
2021-03-02	GW PHARMACEUTICALS PLCShare OptionsA Award	Director, Chief Executive Officer	AAward	+263K sh	—	—	263,184
2021-03-01	GW PHARMACEUTICALS PLCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−8,412 sh	$17.85	−$150K	222,773
2021-03-01	GW PHARMACEUTICALS PLCShare OptionsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−17K sh	—	—	0
2021-03-01	GW PHARMACEUTICALS PLCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+17K sh	$0.00	+$23.806	231,185
2021-02-26	GW PHARMACEUTICALS PLCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+22.4K sh	$0.00	+$31.416	22,445
2021-02-26	GW PHARMACEUTICALS PLCShare OptionsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−101K sh	—	—	0
2021-02-26	GW PHARMACEUTICALS PLCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−148K sh	$17.90	−$2.65M	162,749
2021-02-26	GW PHARMACEUTICALS PLCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+24 sh	$0.00	+$0.034	162,773
2021-02-26	GW PHARMACEUTICALS PLCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−50K sh	$17.90	−$895K	214,181
2021-02-26	GW PHARMACEUTICALS PLCShare OptionsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−22.4K sh	—	—	0
2021-02-26	GW PHARMACEUTICALS PLCShare OptionsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−299K sh	—	—	0
2021-02-26	GW PHARMACEUTICALS PLCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+299K sh	$0.00	+$418.874	310,555
2021-02-26	GW PHARMACEUTICALS PLCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−12 sh	$17.90	−$214.8	162,761
2021-02-26	GW PHARMACEUTICALS PLCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−11.1K sh	$17.90	−$198K	11,359
2021-02-26	GW PHARMACEUTICALS PLCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+101K sh	$0.00	+$141.977	264,173

Recent filings

Accepted (ET)
Jun 114
Gover Justin D.0001754129-26-000006
SEC(opens sec.gov)
Jun 34
Gover Justin D.0001193125-26-256124
SEC(opens sec.gov)
May 294
Gover Justin D.0001754129-26-000004
SEC(opens sec.gov)
Jan 54
Gover Justin D.0001754129-26-000002
SEC(opens sec.gov)
Sep 104
Gover Justin D.0001415889-25-024109
SEC(opens sec.gov)
Jul 304
Gover Justin D.0001816590-25-000099
SEC(opens sec.gov)
Jun 64
Gover Justin D.0000950170-25-083325
SEC(opens sec.gov)
Jun 54
Gover Justin D.0000950170-24-069466
SEC(opens sec.gov)
Aug 104
Gover Justin D.0000950170-23-041534
SEC(opens sec.gov)
May 74
Gover Justin D.0000899243-21-018659
SEC(opens sec.gov)

Companies

Address

C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110

CARLSBAD, CA, 92011